has function has role immunizes against disease immunizes recipient melanoma Homo sapiens melanoma vaccine therapeutic vaccine function vaccine in clinical trial role allogeneic HLA-A2/4-1BB ligand-expressing melanoma vaccine A cancer vaccine that consists of an allogeneic cell line that has a high expression level of melanoma molecules (HLA A2/4-1BB Ligand), and has been genetically modified to induce a strong immune response. Stimulation of the immune response against the tumor can help destroy residual tumor in melanoma patients with very high risk for disease recurrence and in patients with relatively low tumor burden who already got first line treatment for their disease. Jie Zheng Hayleigh Kahn NCT: https://clinicaltrials.gov/study/NCT01861938 8744 3105 Gene name: HLA-A Gene name: 4-1BBL 6313 cancer vaccine VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6313 therapeutic cancer vaccine whole cell cancer vaccine